All Articles
“Navigators can play an important role in assisting patients and caregivers in managing diabetes and cancer treatment,” says oncology nurse navigator Cheryl Bellomo. Read More ›
On April 17, 2017, the FDA approved the PD-L1 inhibitor Tecentriq (atezolizumab; from Genentech) for use as first-line treatment for patients with locally advanced or metastatic urothelial carcinoma who cannot use cisplatin chemotherapy. Read More ›
Ashley Devine has twice battled liver cancer. Throughout her ordeals, she has taken the reins of her treatment options and made tough decisions about her care. Read More ›
This slideshow features stories about patients with cancer and the support provided by their pets. Read More ›
Welcome to the April 2017 issue of CONQUER. As we embark on spring, we also know that cancer takes no season off. No holiday. So as you are enjoying warmer weather, trees with buds, and the grass getting green, take your copy of CONQUER outside with you, get a comfy chair, and start reading. Let’s review some of the highlights in this issue.
Read More ›
Almost all women who have received treatment for breast cancer have a list of questions that they find difficult to ask during a clinical visit with their oncologist. Read More ›